Cooper Companies | COO - Gross Profit On Sales

Stock Price
82.10
Daily Change
2.00 2.50%
Monthly
-2.15%
Yearly
-12.26%
Q1 Forecast
78.87

Cooper Companies reported $650.8M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Align Technology USD 683.59M 44.39M Dec/2025
AtriCure USD 101.33M 150K Sep/2025
Avanos Medical USD 86M 6.1M Sep/2025
Bausch Health Companies USD 1.93B 165M Sep/2025
Baxter International USD 950M 194M Sep/2025
Bayer EUR 5.35B 1.02B Sep/2025
Becton, Dickinson and Co. USD 696M 1.94B Sep/2025
Boston Scientific USD 3.68B 136M Dec/2025
Cooper Companies USD 650.8M 62.6M Sep/2025
Dentsply International USD 441M 49M Sep/2025
Dexcom USD 688.8M 99.8M Jun/2025
Edwards Lifesciences USD 1.19B 76.7M Jun/2025
Globus Medical USD 486.67M 725.06M Sep/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
Insulet USD 510.1M 57.9M Sep/2025
Integra LifeSciences USD 206.99M 2.34M Sep/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
J&J USD 16.6B 118M Dec/2025
Medtronic USD 5.44B 123M Sep/2025
Merit Medical Systems USD 184.49M 12.47M Jun/2025
Novartis USD 10.82B 694M Sep/2025
ResMed USD 878.72M 57.9M Dec/2025
STAAR Surgical USD 77.88M 45.08M Sep/2025
Steris USD 655.5M 9.6M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Tandem Diabetes Care USD 134.29M 8.44M Sep/2025
Teleflex USD 451.64M 20.56M Sep/2025
Zimmer Biomet Holdings USD 1.27B 58.9M Sep/2025